{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:01:54Z","timestamp":1792512114380,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.semarthrit.2024.152610","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T16:15:48Z","timestamp":1735316148000},"page":"152610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Rheumatologic complications of CAR-T Cell therapy. Experience of a single center"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8177-702X","authenticated-orcid":false,"given":"Jos\u00e9 A","family":"G\u00f3mez-Puerta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Monegal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Mart\u00ednez-Cibrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Camilo","family":"Sarmiento-Monroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Ortiz-Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Triguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Fern\u00e1ndez de Larrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Garc\u00eda-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Albero-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bosch-Amate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Espa\u00f1ol-Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azucena","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimon","family":"Sanmart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2024.152610_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/s41584-024-01139-z","article-title":"Advancements and challenges in CAR T cell therapy in autoimmune diseases","author":"Schett","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152610_bib0002","first-page":"keae046","article-title":"Transient palindromic rheumatism induced by chimeric antigen receptor-T cell therapy","author":"G\u00f3mez-Puerta","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152610_bib0003","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ymthe.2020.09.027","article-title":"CART19-BE-01: A multicenter Trial of ARI-0001 cell therapy in patients with CD19+ relapsed\/refractory malignancies","volume":"29","author":"Ort\u00edz-Maldonado","year":"2021","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.semarthrit.2024.152610_bib0004","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1470-2045(23)00222-X","article-title":"Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study","volume":"24","author":"Oliver-Cald\u00e9s","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semarthrit.2024.152610_bib0005","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2024013044","article-title":"CAR T cell Toxicities: Bedside to Bench - How Novel Toxicities Inform Laboratory Investigations","author":"Perna","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.semarthrit.2024.152610_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1396490","article-title":"Mechanisms and management of CAR T toxicity","volume":"14","author":"Ferreri","year":"2024","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152610_bib0007","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jtct.2022.03.006","article-title":"Clinical presentation, risk factors, and outcomes of immune effector cell-associated neurotoxicity syndrome following chimeric antigen receptor T Cell therapy: A systematic review","volume":"28","author":"Grimshaw","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152610_bib0008","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13075-023-03098-4","article-title":"Interleukin-1\u03b2 inhibitors for the management of acute gout flares: a systematic literature review","volume":"25","author":"Schlesinger","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2024.152610_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/631384","article-title":"IL-1 Receptor Blockade Alleviates Graft-versus-Host Disease through Downregulation of an Interleukin-1\u03b2-Dependent Glycolytic Pathway in Th17 Cells","volume":"2015","author":"Park","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"9","key":"10.1016\/j.semarthrit.2024.152610_bib0010","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamadermatol.2020.0636","article-title":"Bullous and exanthematous lesions associated with chimeric antigen receptor T-cell therapy in a patient with diffuse large B-cell lymphoma","volume":"156","author":"Hu","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152610_bib0011","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1097\/MS9.0000000000002188","article-title":"Adverse events associated with chimeric antigen receptor T-cell therapy in ophthalmology: a narrative review","volume":"86","author":"Sarwar","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.semarthrit.2024.152610_bib0012","article-title":"CD-19 CAR-T cells for polyrefractory rheumatoid arthritis","author":"Lidar","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2024.152610_bib0013","first-page":"761","article-title":"Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis","volume":"31","author":"L\u00f3pez-Mej\u00edas","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152610_bib0014","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000345700","article-title":"Serum acute phase protein and inflammatory cytokine network correlations: comparison of a pre-rheumatoid arthritis and non-rheumatoid arthritis community cohort","volume":"5","author":"Masi","year":"2013","journal-title":"J Innate Immun"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152610_bib0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00011-023-01837-6","article-title":"A systematic review and meta-analysis of circulating adhesion molecules in rheumatoid arthritis","volume":"73","author":"Mangoni","year":"2024","journal-title":"Inflamm Res"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152610_bib0016","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006365","article-title":"Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis","volume":"11","author":"Moreno-Casta\u00f1o","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152610_bib0017","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s10067-023-06589-6","article-title":"Rheumatoid nodules: a narrative review of histopathological progression and diagnostic consideration","volume":"42","author":"Fareez","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152610_bib0018","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s10067-023-06589-6","article-title":"Rheumatoid nodules: a narrative review of histopathological progression and diagnostic consideration","volume":"42","author":"Fareez","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152610_bib0019","article-title":"Clinical patterns and follow-up of inflammatory arthritis and other immune-related adverse events induced by checkpoint inhibitors. A multicenter study","volume":"9","author":"G\u00f3mez-Puerta","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152610_bib0020","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1055\/s-0042-1743164","article-title":"A Case of Severe aeromonas bacteremia with necrotizing fasciitis of lower limb and fournier ' s gangrene in a post-allogenic unrelated hematopoietic stem cell transplant recipient","volume":"11","author":"Das","year":"2022","journal-title":"South Asian J Cancer"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152610_bib0021","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s41409-019-0743-6","article-title":"Non-irradiated GCSF stimulated leukocyte transfusion for necrotizing fasciitis after allogeneic stem cell transplant: a case report and review of the literature","volume":"55","author":"Moukalled","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"19","key":"10.1016\/j.semarthrit.2024.152610_bib0022","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.2169\/internalmedicine.50.5829","article-title":"Successful treatment of necrotizing fasciitis in an upper extremity caused by Clostridium perfringens after bone marrow transplantation","volume":"50","author":"Ito","year":"2011","journal-title":"Intern Med"},{"issue":"10","key":"10.1016\/j.semarthrit.2024.152610_bib0023","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.bmt.1701438","article-title":"Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation","volume":"22","author":"Martinelli","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152610_bib0024","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/QCO.0000000000000988","article-title":"Necrotizing fasciitis: an update on epidemiology, diagnostic methods, and treatment","volume":"37","author":"Allaw","year":"2024","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152610_bib0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MD.0000000000000007","article-title":"High prevalence of prothrombotic abnormalities in multifocal osteonecrosis: description of a series and review of the literature","volume":"92","author":"G\u00f3mez-Puerta","year":"2013","journal-title":"Medicine (Baltimore)"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224002506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224002506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T14:51:43Z","timestamp":1741099903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224002506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":25,"alternative-id":["S0049017224002506"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152610","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatologic complications of CAR-T Cell therapy. Experience of a single center","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152610"}}